KalVista Pharmaceuticals, Inc.

NASDAQ:KALV

Biotechnology

Healthcare
$27.00 +0.00%

+$0.00 today

Market cap
$1.44B
Beta
-0.11
P/E (TTM)
-9.9
EPS (TTM)
-$2.74
52W Low $9.83High $27.00

Volume 4.26M

Average 3.47M

Price history

KalVista Pharmaceuticals, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+96.94%

Period high

$27.00

Period low

$13.02

Latest

$27.00

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KJun 11, 2026Jun 11, 2026
4Jun 11, 2026Jun 11, 2026
S-8 POSJun 11, 2026Jun 11, 2026
4Jun 11, 2026Jun 11, 2026
4Jun 11, 2026Jun 11, 2026
S-8 POSJun 11, 2026Jun 11, 2026
25-NSEJun 11, 2026Jun 11, 2026
4Jun 11, 2026Jun 11, 2026
S-8 POSJun 11, 2026Jun 11, 2026
S-8 POSJun 11, 2026Jun 11, 2026
S-8 POSJun 11, 2026Jun 11, 2026
4Jun 11, 2026Jun 11, 2026
S-8 POSJun 11, 2026Jun 11, 2026
S-8 POSJun 11, 2026Jun 11, 2026
S-8 POSJun 11, 2026Jun 11, 2026

Competitors

Who does KalVista Pharmaceuticals, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about KALV's filings, answered from its disclosures.

What is the latest KALV filing?

The latest filing shown is 8-K dated Jun 11, 2026.

How many recent filings does KALV have?

Intrinsic Alpha currently shows 20 recent filings for KALV.